LMCG Investments’s Sanofi SNY Stock Holding History

LMCG Investments’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-39,364	Closed	-$1.96M	–	301
2023 Q4	$1.96M	Sell	39,364 -1,558	-4%	-$76.2K	0.12%	152
2023 Q3	$2.2M	Sell	40,922 -1,899	-4%	-$101K	0.15%	142
2023 Q2	$2.31M	Sell	42,821 -708	-2%	-$38.1K	0.15%	143
2023 Q1	$2.37M	Sell	43,529 -696	-2%	-$33.9K	0.16%	138
2022 Q4	$2.14M	Buy	+44,225	New	+$1.94M	0.15%	145

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

LMCG Investments's SNY Position: Q1 2024 in Review

LMCG Investments sold out of Sanofi (SNY) in Q1 2024, closing a stake of 39,364 shares — an estimated $1.96M sold.

LMCG Investments first reported a position in SNY in Q4 2022 and held it in 5 quarters. The position peaked at $2.37M in Q1 2023. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

LMCG Investments reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
LMCG Investments sold 39,364 Sanofi shares in Q1 2024, an estimated $1.96M.
LMCG Investments first reported a position in Sanofi in Q4 2022 and held it in 5 quarters.
LMCG Investments's Sanofi position peaked at $2.37M in Q1 2023.
713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on LMCG Investments's 13F filing for Q1 2024, filed 6 May 2024.